NuScale Power Stock Is Plunging: What's Causing the Decline

NuScale’s first commercial reactors are not expected online until the early 2030s, and repeated delays tied to inflation, lawsuits, and competition from microreactor rivals have weighed on sentiment. The company now trades at just over $10 after reaching a $53.43 record high on Oct. 15, 2025, while analysts expect 2026 revenue of $56 million and a net loss of $164 million. The stock is valued at 63x this year’s sales, limiting upside unless execution improves materially.

Analysis

The market is telling you this is not a nuclear thesis yet; it is a duration and financing thesis with a long embedded optionality tail. Until first revenue from commercial deployment is visible, SMR behaves like a pre-profit infrastructure venture: every schedule slip forces a higher discount rate, and that effect compounds because the project economics depend on a credible manufacturing learning curve that has not started at scale.

Second-order winners are less obvious than the headline competitor. If SMR’s timeline remains pushed out, capital and policy attention can migrate toward grid bottlenecks, gas peakers, utility-scale storage, and electrification suppliers that can monetize the AI power buildout in 12-36 months rather than the 5-8 year window implied here. FLR is also exposed not just financially but reputationally: repeated delays can make it harder to win adjacent complex EPC work, while OKLO benefits from being perceived as the more “moonshot” alternative even if its own commercialization risk is higher.

The key catalyst path is not reactor startup; it is proof that NuScale can convert design work into a repeatable order book without margin erosion. A meaningful inflection would require either a major utility/sovereign customer that pre-funds deployment milestones, or a sharp move in power prices / data-center demand that shortens the buyer’s patience window. Absent that, the next 6-12 months are more likely to bring dilution risk, legal overhang, and insider selling pressure than fundamental re-rating.

The contrarian case is that the stock may already discount the disappointment on first deployment, but it still likely does not fully discount execution risk on the pathway to commercial scale. If inflation normalizes and financing markets loosen, the name can rally hard on any licensing or FEED headlines; however, that would be a trading response, not a durable fundamental reset. The upside is therefore more likely to come from sentiment compression than from near-term cash-flow visibility.

Key Decisions for Investors

• Avoid initiating new long SMR here; the risk/reward is poor until there is evidence of schedule stabilization. If already long, reduce on strength and treat rallies toward prior breakdown levels as exits over a 1-3 month horizon.
• Pair trade: short SMR / long FLR only if you believe project slippage will keep driving scrutiny onto execution. Use a 3-6 month horizon and keep sizing modest because FLR carries some pass-through exposure to the same delay narrative.
• Relative-value idea: long regulated power/grid beneficiaries against SMR. Prefer names with nearer-term AI/data-center monetization and cash generation; this captures the market’s rotation to delivery rather than aspiration over the next 6-12 months.
• Speculative contrarian trade: buy small, dated call spreads in SMR only on a sharp post-news pullback, not into strength. The setup only works if a licensing or customer-financing headline arrives within the next 1-2 quarters; otherwise theta and dilution risk dominate.
• For higher-risk capital, OKLO can be a cleaner momentum proxy than SMR on a tactical basis, but size it as a sentiment trade, not a fundamentals trade, and pair against a profitable infrastructure name to dampen factor risk.